# Predictors of shunt responsiveness and outcomes in idiopathic normal pressure hydrocephalus: a retrospective cohort study

**Authors:** Dror Shir, Noa Bregman, Jonathan Roth, Elissa Ash, Tamara Shiner

PMC · DOI: 10.1007/s00701-026-06839-x · 2026-03-23

## TL;DR

This study identifies predictors of successful shunt treatment in idiopathic normal pressure hydrocephalus patients, finding that lower CSF tau and a specific brain imaging pattern are linked to better outcomes.

## Contribution

The study introduces new clinical and biomarker predictors for shunt responsiveness in iNPH patients.

## Key findings

- Lower CSF total tau levels were associated with better outcomes after shunt placement.
- A disproportionately enlarged subarachnoid-space hydrocephalus (DESH) pattern was more common in patients who responded well to shunting.

## Abstract

Idiopathic Normal Pressure Hydrocephalus (iNPH) remains a challenging clinical diagnosis with variable treatment response.

This study aimed to identify clinical, imaging, and CSF biomarkers associated with favorable outcomes following shunt placement.

All patients evaluated for iNPH at the Tel-Aviv Medical Center (TLVMC) between 2020 and 2022 were included. Participants underwent clinical, cognitive, and imaging assessments, high-volume lumbar puncture (LP). LP responders were referred for shunt placement, and outcomes assessed at one year.

183 patients were evaluated; 167 met criteria for suspected iNPH and underwent LP. Sixty-two (37%) patients showed improvement after CSF drainage and were referred for shunting. Of these, 38 (61%) underwent shunt placement. Gait disturbance was the most common presenting symptom (68%), and more frequent in LP responders (p = 0.007), whereas cognitive symptoms were more common among non-responders (29.5% vs. 10%). LP responders had lower CSF total tau (t-tau) (222.6 ± 99.1 vs. 256 ± 107.1, p = 0.045) and protein (41.1 ± 17.1 vs. 49.1 ± 25.7, p = 0.032) and were more likely to exhibit a disproportionately enlarged subarachnoid-space hydrocephalus (DESH) pattern (73% vs. 46%, p < 0.001). Among the 38 shunted patients, 21 (55%) had a favourable outcome at one year, which was associated with lower t-tau (p = 0.056) and more frequent DESH (p = 0.026).

Over half of patients who underwent shunt placement experienced favorable clinical outcomes at one year. Lower t-tau and DESH pattern were associated with better outcomes.

## Linked entities

- **Diseases:** hydrocephalus (MONDO:0001150)

## Full-text entities

- **Genes:** CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}
- **Diseases:** glymphatic dysfunction (MESH:D006331), LP (MESH:D051299), ventricular enlargement (MESH:D006332), ICH (MESH:D002543), atrophy (MESH:D001284), depression (MESH:D003866), demyelination (MESH:D003711), visual hallucinations (MESH:D006212), DESH (MESH:D013345), White matter hyperintensities (MESH:D056784), REM sleep behavior disorder (MESH:D020187), diabetes (MESH:D003920), headaches (MESH:D006261), gait impairment (MESH:D020234), neurodegeneration (MESH:D019636), cognitive symptoms (MESH:D019954), urinary incontinence (MESH:D014549), Parkinson's disease (MESH:D010300), cognitive impairment (MESH:D003072), parkinsonism (MESH:D010302), progressive supranuclear palsy (MESH:D013494), hydrocephalus (MESH:D006849), Gait disturbance (MESH:D020233), cerebrovascular disease (MESH:D002561), hyperlipidemia (MESH:D006949), ischemic changes (MESH:D002545), chronic kidney disease (MESH:D051436), urinary symptoms (MESH:D059411), ischemic heart disease (MESH:D017202), obstructive sleep apnea (MESH:D020181), vascular disease (MESH:D014652), intracranial hemmorhage (MESH:D001932), LBD (MESH:D020961), Idiopathic Normal Pressure Hydrocephalus (MESH:D006850), hypertension (MESH:D006973), AD (MESH:D000544)
- **Chemicals:** FDG (MESH:D019788), DESH (-), FDOPA (MESH:C043437)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13009103/full.md

---
Source: https://tomesphere.com/paper/PMC13009103